{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T20:07:51Z","timestamp":1792786071749,"version":"4.5.0"},"reference-count":26,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T00:00:00Z","timestamp":1789171200000},"content-version":"vor","delay-in-days":254,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Carver College of Medicine and the Holden Comprehensive Cancer Center","id":[{"id":"https:\/\/ror.org\/01jhe7086","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","award":["P30 CA086862"],"award-info":[{"award-number":["P30 CA086862"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Glioblastoma (GBM) represents the most common and aggressive central nervous system malignancy where overall survival is a dismal 14.6 months despite an aggressive standard of care treatment regimen that includes maximally safe surgical resection, radiotherapy, and temozolomide. It has recently been established that GBM tumors have increased transferrin receptor expression and iron content which corresponds with worse patient prognosis. This has led to the hypothesis that iron metabolism is a viable therapeutic target. An emergent therapeutic strategy to target GBM iron metabolism is gallium maltolate (GaM), which is an orally bioavailable form of Ga3+ that functions as a redox inactive iron mimic to disrupt iron metabolism. As mitochondrial iron metabolism serves as a central connection point between iron and DNA metabolism, the goal of this study was to determine if GaM could disrupt this system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The effects of GaM on GBM cells were interrogated using conventional techniques including colony formation assays to assess clonogenicity, alkaline comet assays to evaluate DNA damage induction, and Mito-FerroGreen analysis to evaluate mitochondrial iron content. The effects of GaM on tumor growth in vivo were evaluated using a subcutaneous flank xenograft model system to determine the induction of DNA damage and an orthtopic model system to evaluate the combinatorial effects of GaM, radiation, and temozolomide on murine survival.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>This study uncovered that maintenance of high mitochondrial iron content corresponds with increased proliferative capacity in GBM cells. This study also shows that GaM can deplete mitochondrial iron to induce DNA damage both in vitro and in a subcutaneous xenograft model. Furthermore, GaM enhances the efficacy of radiation and temozolomide when delivered concomitant and adjuvantly in an orthotopic GBM model system.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These results suggest that GaM warrants further consideration for use in combination with standard of care GBM therapy.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/noajnl\/vdag246","type":"journal-article","created":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T11:51:55Z","timestamp":1789127515000},"source":"Crossref","is-referenced-by-count":0,"title":["Gallium maltolate causes genomic instability to enhance glioblastoma response to radiation and temozolomide"],"prefix":"10.1093","volume":"8","author":[{"given":"Joan N","family":"Whittier","sequence":"first","affiliation":[{"name":"University of Iowa Department of Radiation Oncology, , Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephenson B","family":"Owusu","sequence":"additional","affiliation":[{"name":"University of Iowa Department of Radiation Oncology, , Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Cooke","sequence":"additional","affiliation":[{"name":"University of Iowa Department of Radiation Oncology, , Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jann N","family":"Sarkaria","sequence":"additional","affiliation":[{"name":"Mayo Clinic Department of Radiation Oncology, , Rochester, Minnesota"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7581-1172","authenticated-orcid":false,"given":"Michael S","family":"Petronek","sequence":"additional","affiliation":[{"name":"University of Iowa Department of Radiation Oncology, , Iowa City, Iowa"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,9,11]]},"reference":[{"key":"2026100914464321100_vdag246-B1","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1056\/NEJMra0708126","article-title":"Malignant gliomas in adults","volume":"359","author":"Wen Patrick","year":"2008","journal-title":"N Engl J Med"},{"key":"2026100914464321100_vdag246-B2","doi-asserted-by":"publisher","first-page":"v1","DOI":"10.1093\/neuonc\/nox158","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2010\u20132014","volume":"19","author":"Ostrom","year":"2017","journal-title":"Neuro-Oncology."},{"key":"2026100914464321100_vdag246-B3","doi-asserted-by":"publisher","first-page":"iv1","DOI":"10.1093\/neuonc\/noaa200","article-title":"CBTRUS statistical report: primary brain and other central nervous system tumors diagnosed in the United States in 2013\u20132017","volume":"22","author":"Ostrom","year":"2020","journal-title":"Neuro-Oncology"},{"key":"2026100914464321100_vdag246-B4","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1001\/jamaoncol.2018.1789","article-title":"Adult glioma incidence and survival by race or ethnicity in the United States from 2000 to 2014","volume":"4","author":"Ostrom","year":"2018","journal-title":"JAMA Oncol"},{"key":"2026100914464321100_vdag246-B5","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1056\/NEJMoa1308573","article-title":"A randomized trial of bevacizumab for newly diagnosed glioblastoma","volume":"370","author":"Gilbert","year":"2014","journal-title":"N Engl J Med"},{"key":"2026100914464321100_vdag246-B6","doi-asserted-by":"publisher","first-page":"2306","DOI":"10.1001\/jama.2017.18718","article-title":"Effect of tumor-treating fields plus maintenance temozolomide vs maintenance temozolomide alone on survival in patients with glioblastoma: a randomized clinical trial","volume":"318","author":"Stupp","year":"2017","journal-title":"JAMA"},{"key":"2026100914464321100_vdag246-B7","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1016\/S1470-2045(09)70025-7","article-title":"Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial","volume":"10","author":"Stupp","year":"2009","journal-title":"Lancet Oncol"},{"key":"2026100914464321100_vdag246-B8","doi-asserted-by":"publisher","first-page":"987","DOI":"10.1056\/NEJMoa043330","article-title":"Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma","volume":"352","author":"Stupp","year":"2005","journal-title":"N Engl J Med"},{"key":"2026100914464321100_vdag246-B9","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1158\/1078-0432.CCR-22-3952","article-title":"Magnetic resonance imaging of iron metabolism with T2 mapping predicts an enhanced clinical response to pharmacologic ascorbate in patients with GBM","volume":"30","author":"Petronek","year":"2024","journal-title":"Clin Cancer Res"},{"key":"2026100914464321100_vdag246-B10","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1038\/s42003-022-03538-y","article-title":"Iron commensalism of mesenchymal glioblastoma promotes ferroptosis susceptibility upon dopamine treatment","volume":"5","author":"Vo","year":"2022","journal-title":"Commun Biol"},{"key":"2026100914464321100_vdag246-B11","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1016\/j.ccell.2015.09.002","article-title":"Preferential iron trafficking characterizes glioblastoma stem-like cells","volume":"28","author":"Schonberg","year":"2015","journal-title":"Cancer Cell"},{"key":"2026100914464321100_vdag246-B12","doi-asserted-by":"publisher","first-page":"1458","DOI":"10.3390\/antiox10091458","article-title":"Iron-sulfur cluster biogenesis as a critical target in cancer","volume":"10","author":"Petronek","year":"2021","journal-title":"Antioxidants"},{"key":"2026100914464321100_vdag246-B13","doi-asserted-by":"publisher","first-page":"1152398","DOI":"10.3389\/fgene.2023.1152398","article-title":"Maintenance of genome integrity by the late-acting cytoplasmic iron-sulfur assembly (CIA) complex","volume":"14","author":"Petronek","year":"2023","journal-title":"Front Genet"},{"key":"2026100914464321100_vdag246-B14","doi-asserted-by":"publisher","first-page":"536","DOI":"10.1007\/BF00571645","article-title":"Transferrin receptors and gallium-67 uptake in vitro","volume":"7","author":"Chen","year":"1982","journal-title":"Eur J Nucl Med"},{"key":"2026100914464321100_vdag246-B15","doi-asserted-by":"publisher","first-page":"1240","DOI":"10.1158\/1535-7163.MCT-17-1009","article-title":"Gallium maltolate disrupts tumor iron metabolism and retards the growth of glioblastoma by inhibiting mitochondrial function and ribonucleotide reductase","volume":"17","author":"Chitambar","year":"2018","journal-title":"Mol Cancer Ther"},{"key":"2026100914464321100_vdag246-B16","doi-asserted-by":"publisher","DOI":"10.3390\/ijms251810047","article-title":"Gallium uncouples iron metabolism to enhance glioblastoma radiosensitivity","volume":"25","author":"Owusu","year":"2024","journal-title":"Int J Mol Sci"},{"key":"2026100914464321100_vdag246-B17","doi-asserted-by":"publisher","first-page":"10775","DOI":"10.1073\/pnas.0912925107","article-title":"Mitochondrial iron trafficking and the integration of iron metabolism between the mitochondrion and cytosol","volume":"107","author":"Richardson","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026100914464321100_vdag246-B18","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21144910","article-title":"Targeting the DNA damage response to overcome cancer drug resistance in glioblastoma","volume":"21","author":"Ferri","year":"2020","journal-title":"Int J Mol Sci"},{"key":"2026100914464321100_vdag246-B19","doi-asserted-by":"publisher","first-page":"1077","DOI":"10.3390\/cancers11081077","article-title":"Linking cancer metabolic dysfunction and genetic instability through the lens of iron metabolism","volume":"11","author":"Petronek","year":"2019","journal-title":"Cancers (Basel)"},{"key":"2026100914464321100_vdag246-B20","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1128\/MCB.01685-08","article-title":"Regulation of mitochondrial iron import through differential turnover of mitoferrin 1 and mitoferrin 2","volume":"29","author":"Paradkar","year":"2009","journal-title":"Mol Cell Biol"},{"key":"2026100914464321100_vdag246-B21","doi-asserted-by":"publisher","first-page":"349","DOI":"10.3390\/antiox12020349","article-title":"Mitoferrin-1 promotes proliferation and abrogates protein oxidation via the glutathione pathway in glioblastoma","volume":"12","author":"Ali","year":"2023","journal-title":"Antioxidants"},{"key":"2026100914464321100_vdag246-B22","doi-asserted-by":"publisher","first-page":"1278157","DOI":"10.3389\/fonc.2023.1278157","article-title":"Potent in vivo efficacy of oral gallium maltolate in treatment-resistant glioblastoma","volume":"13","author":"Al-Gizawiy","year":"2023","journal-title":"Front Oncol"},{"key":"2026100914464321100_vdag246-B23","doi-asserted-by":"publisher","first-page":"978","DOI":"10.1016\/j.ijrobp.2013.04.034","article-title":"Pulsed versus conventional radiation therapy in combination with temozolomide in a murine orthotopic model of glioblastoma multiforme","volume":"86","author":"Lee","year":"2013","journal-title":"Int J Rad Oncol Biol Phys"},{"key":"2026100914464321100_vdag246-B24","doi-asserted-by":"publisher","first-page":"vdag154","DOI":"10.1093\/noajnl\/vdag154","article-title":"A phase 1 trial of iron metabolism-targeting oral gallium maltolate in recurrent and refractory glioblastoma","volume":"8","author":"Connelly","year":"2026","journal-title":"Neuro-Oncology Adv"},{"key":"2026100914464321100_vdag246-B25","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1016\/j.nec.2017.02.007","article-title":"Reoperation for recurrent glioblastoma multiforme","volume":"28","author":"Robin","year":"2017","journal-title":"Neurosurg Clin N Am"},{"key":"2026100914464321100_vdag246-B26","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.3390\/cancers15174279","article-title":"Recurrent glioblastoma: a review of the treatment options","volume":"15","author":"Vaz-Salgado","year":"2023","journal-title":"Cancers (Basel)"}],"container-title":["Neuro-Oncology Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/noa\/advance-article-pdf\/doi\/10.1093\/noajnl\/vdag246\/71035090\/vdag246.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/8\/1\/vdag246\/71035090\/vdag246.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/noa\/article-pdf\/8\/1\/vdag246\/71035090\/vdag246.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T18:46:48Z","timestamp":1791571608000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/noa\/article\/doi\/10.1093\/noajnl\/vdag246\/8790852"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,12]]}},"URL":"https:\/\/doi.org\/10.1093\/noajnl\/vdag246","relation":{},"ISSN":["2632-2498"],"issn-type":[{"value":"2632-2498","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,1]]},"published":{"date-parts":[[2026,1]]},"article-number":"vdag246"}}